Indonesia speeds up new TB vaccine development to combat rising cases
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
For years, the human papillomavirus (HPV) vaccine has been widely recognized as a crucial weapon against cervical cancer in women.
India’s billionaire "vaccine prince" Adar Poonawalla has reached a deal for London’s most expensive home sale of the year, agreeing to pay about 138 mn pound for a 25,000 square foot Mayfair mansion, media reports said.
Covavax is currently under trial and has shown excellent results down to the age of 3 years, Poonawalla said while addressing an event at the Confederation of Indian Industries (CII).
The vaccination drive in the country has been ramped up through the availability of more vaccines, advanced visibility of vaccine availability to states and UT for enabling better planning by them and streamlining the vaccine supply chain.
Responding to a question during the Question House in the Lower House, he also said that the Omicron surfaced on November 1 and on November 24 this was reported in South Africa.
He was speaking as India’s G20 Sherpa at the first Sherpa meeting convened by Indonesia, the current G20 President, in virtual mode.
PM Modi took to social media platform, Twitter to laud the state government which was shared by Thakur who thanked him for continued support to the government that led to the achieving of the vaccination target.
